2nd Annual Effective Coordination of Clinical Trials (BALS47)
Venue: Hotel Radisson SAS
|Event Date/Time: Apr 17, 2007||End Date/Time: Apr 18, 2007|
Every pharma company wants more feasible Clinical Trials which meet their scientific and commercial expectations. There are new trends in clinical development. Beyond outsourcing in low-cost countries, pharma companies try to adapt to local culture, adjust all processes to the legislative specifics and optimize data communication systems.
For the successful launch of new medicines, effective coordination and well-designed project management is a must.
Our conference will provide you with examples on new strategies in patient recruitment speeding. High-quality study data cannot be delivered without well-trained clinical research professionals. Don’t miss the opportunity to listen to practical case studies on clinical career planning and educational programs for people who are in the first contact with patients.
Our prestigious speakers will present you real-life models of outsourced Clinical Trials. You can discuss with them how to measure performance and how to build the satisfaction service with Contract Research Organizations.
Network with other decision makers, share your experience and get new ideas for your work
James P. Kremidas, Global Enrollment Optimization, Eli Lilly & Co.
Hanne Lang, Director Clinical Operations, Novo Nordisk
Rudolf Widmann, Clinical Quality Assurance Auditor, Boehringer Ingelheim
Brian B. O’Neill, Global Head, CQA Management External Alliances, F. Hoffman – La Roche
Yves E. G. Geysels, Head of International Clinical Research Operations, Novartis
Anna Mrowiec, Head of Clinical Research, Pfizer
Regulatory compliance and impact of European legislation on whole Clinical Trials process, presentation from European Commission
New challenging strategies in patient recruitment, case study from Eli Lilly & Co.
Satisfaction service – building relationship with CRO, case study from Pfizer
Auditing in Outsourced Clinical Trials, case study from Boehringer Ingelheim
Achieving greater efficiencies in the quality management of service providers routinely engaged for Clinical Trials, case study from F. Hoffman – La Roche
Motivate and train CRA’s study specifically, case study from Lundbeck